BTG PLC (BTG)

London
840.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    839.00 - 840.00

BTG Overview

Prev. Close
839.5
Day's Range
839-840
Revenue
914.1M
Open
839.5
52 wk Range
0-0
EPS
0.23
Volume
0
Market Cap
3.26B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
638,109
P/E Ratio
35.80
Beta
0.348
1-Year Change
0%
Shares Outstanding
387,968,171
Next Earnings Date
-
What is your sentiment on BTG?
or
Vote to see community's results!

BTG PLC News

BTG PLC Analysis

BTG PLC Company Profile

BTG PLC Company Profile

Employees
1724

BTG Limited provides various therapeutic solutions for a range of complex medical problems in the United States, Europe, and internationally. Its interventional oncology products include TheraSphere, and embolization and chemoembolization polymer beads that are used in the treatment of primary liver cancer, as well as when tumours from other organs spread to the liver; and cryoablation systems and needles. The company’s vascular products comprise EKOS blood clot treatment devices, arterial blockage crossing devices, and Sentry inferior vena cava filters, as well as Varithena, a varicose vein treatment product. It also offers PneumRx, a coils emphysema technology; and acute care products that provide rescue medication to patients. The company was incorporated in 1991 and is based in London, the United Kingdom. BTG Limited operates as a subsidiary of Bravo Bidco Limited.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyNeutralStrong BuyStrong Buy
SummaryStrong BuyStrong BuyBuyStrong BuyStrong Buy